Class IIIReported 2025-10-22

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Recalled by STAQ Pharma, Inc.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Recall Number

D-0024-2026

Classification

Class III

Status

Ongoing

Category

drug

Initiated

2025-10-09

Reported

2025-10-22

Distribution

Nationwide in the U.S.

Code Info

Lot #: 25156673A, Expiry: 02FEB2026.

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.